Ace inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients
Open Access
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 35 (6) , 1076-1082
- https://doi.org/10.1016/s0272-6386(00)70043-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Angiotensin Converting Enzyme Inhibitors Are Associated with the Need for Increased Recombinant Human Erythropoietin Maintenance Doses in Hemodialysis PatientsNephron, 1997
- Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?American Journal of Kidney Diseases, 1996
- Subtherapeutic erythropoietin and insulin-like growth factor-1 correct the anemia of chronic renal failure in the mouseKidney International, 1996
- Unresponsiveness to recombinant human erythropoietin in haemodialysis patients: possible implications of angiotensin-converting enzyme inhibitorsNephrology Dialysis Transplantation, 1996
- Effect of Ängiotensin-Converting Enzyme Inhibitors on Anemia in Hemodialyzed PatientsNephron, 1996
- ANGIOTENSIN-CONVERTING ENZYME INHIBITION IN THE TREATMENT OF RENAL TRANSPLANT ERYTHROCYTOSIS CLINICAL EXPERIENCE AND OBSERVATION OF MECHANISMTransplantation, 1995
- CORRECTION OF POSTTRANSPLANT ERYTHROCYTOSIS WITH ENALAPRILTransplantation, 1994
- ACTH and angiotensin II regulation of insulin-like growth factor-I and its binding proteins in cultured bovine adrenal cellsJournal of Molecular Endocrinology, 1991
- Angiotensin-Converting Enzyme Inhibitor and Anemia in a Patient Undergoing HemodialysisNephron, 1991
- Worsening of Anemia Induced by Long-Term Use of Captopril in Hemodialysis PatientsAmerican Journal of Nephrology, 1984